Indian Army Pharmaceutical Medication Procurement for Critical Drug Formulations

This tender, issued by the Department of Military Affairs under the Ministry of Defence for the Indian Army, presents a significant procurement opportunity for a comprehensive range of pharmaceutical medications. Identified by Bid Number GEM/2026/B/8137201, this tender has a submission window commencing on October 22, 2026, at 11:43 AM and concluding on November 5, 2026, at 12:00 PM. The core of this procurement, as outlined in the Bill of Quantities (BOQ) titled "CDL DRUGS," encompasses a substantial total quantity of 846,660 units across various critical drug formulations. Specifically, the required items include Ranolazine 500 mg Tab, Ranolazine SR 500mg Tab, Spironolactone 25 mg Tab, Tolvaptan 15mg Tab, Trimetazidine 20mg Tab, Trimetazidine MR 35mg Tab, Bisoprolol 2.5 mg Tab, Bisoprolol 5 mg Tab, Nebivolol 2.5mg Tab, Nebivolol 5mg Tab, Nicorandil 5mg Tab, Ubidecarenone 300 mg Tab, Dapagliflozin 5 mg Tab, Gliclazide 40 mg Tab, Gliclazide 80 mg Tab, and Glipizide 5 mg Tab. This tender is being managed by the office located in Panchkula, and interested parties are encouraged to prepare their proposals to meet the outlined requirements and deadlines.